1. Pisters PW, et Al. Sarcomas ofsoft tissue. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG, eds. Clinical oncology. 3rd ed. New York, NY: Churchill Livingstone, 2004; chap 97.
2. Harcke HT, et Al. Evaluation of the musculoskeletal system with sonography.AJR Am J Roentgenol 1988;150(6):1253–1261.
3. Trojani M, et Al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984; 33: 37–42.
4. Dalinka MK, et Al. The use of magnetic resonance imaging in the evaluation of bone and soft-tissue tumors. Radiol Clin North Am 1990;28(2):461–470.
5. Simon MA, Finn HA. Diagnostic strategy for bone and soft-tissue tumors. J Bone Joint Surg Am 1993;75(4):622–631.
6. Emma Robinson, et Al, Multidisciplinary management of tissue sarcoma, RadioGraphics 2008; 28:2069–2086.
7. Liu QY, et Al. Correlation of MRI features to histopathologic grade of soft tissue sarcoma. Ai Zheng 2008;27(8):856–860.
8. Fernebro J, et Al. Focus on the tumour periphery in MRI evaluation of soft tissue sarcoma: infiltrative growth signifies poor prognosis. Sarcoma 2006;2006:21251.
9. Fang Zhao, et Al. Montgomery, John A. Carrino, Laura M. Fayad, Can MR Imaging Be Used to Predict Tumor Grade in Soft-Tissue Sarcoma? Radiology, 2014 ; 272: 192-201.
10. A. Lo´pez-Pousa, et Al, SEOM Clinical Guideline of management of soft-tissue sarcoma (2016),Clin TranslOncol (2016) 18:1213–1220.
11. European Sarcoma Networking Group. Soft tissue and visceralsarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow up. Ann Oncol. 2017; 25: 2-12.
12. Ma LD, et Al. Benign and malignant musculoskeletal masses: MR imaging differentiation with rim-to-center differential enhancement ratios. Radiology 1997;202(3):739–744.
13. Coindre JM, et al. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 1986;58(2):306–309.